These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


140 related items for PubMed ID: 4301942

  • 1. [Treatment of malignant brain tumors by BAR therapy].
    Hoshino T.
    No To Shinkei; 1968 Jun; 20(6):601-11. PubMed ID: 4301942
    [No Abstract] [Full Text] [Related]

  • 2. [Treatment of malignant brain tumors by the intrathecal administration of BAR (EUdR-antimetabolite-radiation)].
    Takakura K, Matsutani M, Koyama Y, Sing OK.
    No To Shinkei; 1972 May; 24(5):585-93. PubMed ID: 4340910
    [No Abstract] [Full Text] [Related]

  • 3. [Clinical experience in the treatment of malignant brain tumors with small dose radiotherapy and showdomycin].
    Kamano S, Amano K, Hanamura T, Fankhauser H, Hatanaka H.
    No To Shinkei; 1977 Apr; 29(4):407-13. PubMed ID: 193544
    [No Abstract] [Full Text] [Related]

  • 4. Management of some intracranial tumors in children and adults.
    Bloom HJ.
    Prog Clin Biol Res; 1978 Apr; 25():55-84. PubMed ID: 216024
    [No Abstract] [Full Text] [Related]

  • 5. Pathologic tumor type and response to treatment.
    Davis RL.
    Natl Cancer Inst Monogr; 1977 Dec; 46():83-7. PubMed ID: 206839
    [Abstract] [Full Text] [Related]

  • 6. [Combined treatment of glyal and metastatic tumors of the brain].
    Fadeev BP, Zhabina RM.
    Vestn Khir Im I I Grek; 2005 Dec; 164(1):80-2. PubMed ID: 15957817
    [Abstract] [Full Text] [Related]

  • 7. [Dynamics of neurological symptoms in patients with brain tumors during combined therapy (operation plus betatron electromagnetic radiation)].
    Samoĭlov VI.
    Vopr Neirokhir; 1967 Dec; 31(2):42-6. PubMed ID: 4298167
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Primary tumors of the central nervous system: histogenetic classification, grade of malignity, clinico-pathologic features, and therapeutic criteria].
    Bisceglia M, D'Angelo V, Parisi S, Lelli G, Pasquinelli G, Cenacchi G, Giangaspero F.
    Pathologica; 2000 Dec; 92(6):534-61. PubMed ID: 11234305
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Intracranial tumors in India: incidence and variations.
    Ramamurthi B.
    Int Surg; 1973 Aug; 58(8):542-7. PubMed ID: 4353995
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. T cell adoptive immunotherapy of newly diagnosed gliomas.
    Plautz GE, Miller DW, Barnett GH, Stevens GH, Maffett S, Kim J, Cohen PA, Shu S.
    Clin Cancer Res; 2000 Jun; 6(6):2209-18. PubMed ID: 10873070
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.